Search

everythinglearnresearchcommunity

for

Search:↓

Researchers made a detailed map of gene activity for different parts of human hair follicles to help create targeted hair disorder treatments.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

HA-P5 effectively treats acne without causing side effects seen in other treatments.

Rac1 is crucial for normal hair structure and pigmentation.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

BAF200 is essential for proper heart and coronary artery formation.

FERONIA is crucial for plant growth, pollen tube reception, and sugar signaling.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Fractional laser resurfacing is effective and safe for skin treatment, with benefits like less downtime and a low risk of adverse events.

Isotretinoin at low doses effectively treats facial papules in frontal fibrosing alopecia.

Acinetobacter strain A1-4-2 can safely clean water pollutants.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Fusidic acid can be an effective topical treatment for superficial bacterial infections in dogs.

Rb-bFGF improves hair transplant results and patient satisfaction with fewer complications.

Ablative fractional resurfacing could improve how well topical drugs penetrate the skin, but more research is needed to fine-tune the method.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Fluorescence can effectively measure acne treatment progress.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Combining PRS with TAFR is promising for treating complex fistulas, with most patients achieving long-term healing.

Leucocyte-rich platelet-rich plasma boosts cell activity and helps wound healing.

The combination treatment showed a higher response rate but no significant survival benefits.

FERONIA and LRX proteins help control cell growth in plants by regulating vacuole expansion.

rwSALT provides precise hair regrowth measurement from scalp photos.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.